|
PSD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.07650000000537E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.255450E-03 |
| Normal-vs-Stage2 |
1.155560E-01 |
| Normal-vs-Stage3 |
1.706750E-01 |
| Normal-vs-Stage4 |
6.158000E-01 |
| Stage1-vs-Stage2 |
3.674400E-01 |
| Stage1-vs-Stage3 |
1.807000E-01 |
| Stage1-vs-Stage4 |
4.609800E-01 |
| Stage2-vs-Stage3 |
2.163600E-01 |
| Stage2-vs-Stage4 |
2.246400E-01 |
| Stage3-vs-Stage4 |
8.511800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.001000E-04 |
| Normal-vs-AfricanAmerican |
1.570160E-02 |
| Normal-vs-Asian |
1.138600E-01 |
| Caucasian-vs-AfricanAmerican |
7.692000E-01 |
| Caucasian-vs-Asian |
7.90449999999998E-05 |
| AfricanAmerican-vs-Asian |
7.199200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.923160E-03 |
| Normal-vs-Female |
4.804700E-04 |
| Male-vs-Female |
3.883700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.876400E-02 |
| Normal-vs-Extreme_Weight |
9.080000E-03 |
| Normal-vs-Obese |
4.259200E-03 |
| Normal-vs-Extreme_Obese |
9.006000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.351400E-01 |
| Normal_Weight-vs-Obese |
2.392200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.145000E-01 |
| Extreme_Weight-vs-Obese |
9.668000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.092200E-01 |
| Obese-vs-Extreme_Obese |
6.314000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.370000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.37459999999912E-05 |
| Normal-vs-Age(61-80Yrs) |
1.244350E-02 |
| Normal-vs-Age(81-100Yrs) |
7.368800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.611000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.898210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.907700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.983200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.714150E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.130360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.624000E-04 |
| Normal-VS-Type2 PRCC |
4.563600E-01 |
| Normal-VS-KIRP CIMP |
1.377370E-01 |
| Normal-VS-Unclassified PRCC |
6.950500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.470030E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.822000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.166800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.629850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.184000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.245600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.161600E-01 |
| Normal-vs-N1 |
2.312800E-01 |
| Normal-vs-N2 |
1.074770E-01 |
| N0-vs-N1 |
3.332000E-01 |
| N0-vs-N2 |
1.235470E-03 |
| N1-vs-N2 |
6.527200E-01 |
|
|
